Study Stopped
Terminated at time of CR - 3.26.2019 - JA
Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis
2 other identifiers
observational
240
1 country
1
Brief Summary
The goal of this research study is to learn if a support group program is acceptable for patients with prostate cancer or patients with breast cancer. Researchers also want to learn if the characteristics of the members of the support group program can have an effect on the quality of life of other members of the support group program. Support group programs will be conducted separately for prostate cancer patients and breast cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2008
CompletedFirst Posted
Study publicly available on registry
November 26, 2008
CompletedStudy Start
First participant enrolled
May 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 26, 2019
CompletedMay 15, 2019
May 1, 2019
9.9 years
November 24, 2008
May 13, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient Psychological Functioning and Quality of Life (QOL)
Baseline and Month 3: Questionnaires & Support Group Assessments
Secondary Outcomes (1)
To study if the characteristics of the members of the support group program can have an effect on the quality of life of other members of the support group program.
2 Years
Study Arms (3)
Homogeneous Support Group
Heterogeneous Support Group One
Heterogeneous Support Group Two
Interventions
10 weekly group meetings lasting 2 hours.
Surveys
Eligibility Criteria
Participants, 21 years of age or older, diagnosed with Prostate Cancer or Breast Cancer.
You may qualify if:
- Diagnosis of prostate or breast cancer, regardless of treatment
- No evidence of metastatic disease
- Able to read, speak, and write English
- Resides within one hour of M.D. Anderson Cancer Center
- years of age or older
- Able to provide meaningful informed consent as judged by a research team member
- Being a distressed patient: a T score greater than or equal to 63 on the Global Severity Index (GSI) of the Brief Symptom Inventory (BSI) or a T score greater than or equal to 63 on any two primary dimensions of this measure, or being a non-distressed patient: a T score of \< 63 on the GSI and a T score of \<63 on all primary dimensions of the BSI.
You may not qualify if:
- \) None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cindy L Carmack Taylor, PHD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 24, 2008
First Posted
November 26, 2008
Study Start
May 1, 2009
Primary Completion
March 26, 2019
Study Completion
March 26, 2019
Last Updated
May 15, 2019
Record last verified: 2019-05